Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(583)
Ayalew Tefferi
43
Curtis A. Hanson
24
Martin S. Tallman
22
John M. Bennett
21
Sarah F. Paternoster
21
Journals
(42)
CANCER GENET CYTOGENET
24
LEUK RES
22
AMER J MED GENET
21
BRIT J HAEMATOL
13
Leukemia
10
Keywords
(237)
Embed
Subscribe
Academic
Authors
Gordon W. Dewald
Gordon W. Dewald,Mayo Clinic,Oncology,Genetics & Genealogy,Pathology
Edit
Gordon W. Dewald
Mayo Clinic
Publications:
197
|
Citations:
4571
Fields:
Oncology
,
Genetics & Genealogy
,
Pathology
View FAQ about top research areas and Fields of study
Collaborated with
583 co-authors
from 1987 to 2010
|
Cited by
12860 authors
Cumulative
Annual
Sort by:
Publications
(197)
BibTeX
|
RIS
|
RefWorks
Download
Activating FLT3 mutations in CD117/KIT T-cell acute lymphoblastic leukemias
(
Citations: 11
)
Elisabeth Paietta
,
Adolfo A. Ferrando
,
Donna Neuberg
,
John M. Bennett
,
Janis Racevskis
,
Hillard Lazarus
,
Gordon Dewald
,
Jacob M. Rowe
,
Peter H. Wiernik
,
Martin S. Tallman
,
A. Thomas Look
Published in 2010.
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group
(
Citations: 2
)
Mark R. Litzow
,
Megan Othus
,
Larry D. Cripe
,
Steven D. Gore
,
Hillard M. Lazarus
,
Sandra J. Lee
,
John M. Bennett
,
Elisabeth M. Paietta
,
Gordon W. Dewald
,
Jacob M. Rowe
,
Martin S. Tallman
Journal:
British Journal of Haematology - BRIT J HAEMATOL
, vol. 148, no. 2, pp. 217-225, 2010
UKALLXII/ECOG2993 the pre-imatinib era: results from the International ALL Trial MRC confirms superiority of allogeneic transplantation over chemotherapy in Philadelphia chromosomepositive acute lymphoblastic leukemia Prospective outcome data on 267 unselected adult patients with
Anthony H. Goldstone
,
Gordon Dewald
,
Ian M. Franklin
,
Selina M. Luger
,
Elisabeth Paietta
,
Peter H. Wiernik
,
Martin S. Durrant
,
David I. Marks
,
Andrew K. McMillan
,
Mark R. Litzow
,
Hillard M. Lazarus
,
Letizia Foroni
http://academic.research.microsoft.com/io.ashx?type=5&id=14291042&selfId1=23552990&selfId2=0&maxNumber=12&query=
Published in 2010.
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium
Stephanie A. Smoley
,
Daniel L. Van Dyke
,
Neil E. Kay
,
Nyla A. Heerema
,
Marie L. Dell’ Aquila
,
Paola Dal Cin
,
Prasad Koduru
,
Ayala Aviram
,
Laura Rassenti
,
John C. Byrd
,
Kanti R. Rai
,
Jennifer R. Brown
Gordon W. Dewald
http://academic.research.microsoft.com/io.ashx?type=5&id=49197417&selfId1=23552990&selfId2=0&maxNumber=12&query=
Journal:
Cancer Genetics and Cytogenetics - CANCER GENET CYTOGENET
, vol. 203, no. 2, pp. 141-148, 2010
first or second complete remission hematopoietic stem cell transplantation for acute myeloid leukemia in Impact of cytogenetics on outcome of matched unrelated donor
Meir Wetzler
,
Daniel J. Weisdorf
,
M. Lazarus
,
Mark R. Litzow
,
Jayesh Mehta
,
Tanya Pedersen
,
Waleska S. Pérez
,
Jacob M. Rowe
,
Martin S. Tallman
,
Gordon W. Dewald
,
Brent R. Logan
,
Armand Keating
Published in 2010.
Sort by:
Citations
(4571 times by 3388 publications)
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S K Kumar
,
J H Lee
,
J J Lahuerta
,
G Morgan
,
P G Richardson
,
J Crowley
,
J Haessler
,
J Feather
,
A Hoering
,
P Moreau
,
X LeLeu
,
C Hulin
http://academic.research.microsoft.com/io.ashx?type=5&id=56564055&selfId1=23552990&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 1, pp. 149-157, 2012
Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia
Altuna Akalin
,
Francine E. Garrett-Bakelman
,
Matthias Kormaksson
,
Jennifer Busuttil
,
Lu Zhang
,
Irina Khrebtukova
,
Thomas A. Milne
,
Yongsheng Huang
,
Debabrata Biswas
,
Jay L. Hess
,
C. David Allis
,
Robert G. Roeder
http://academic.research.microsoft.com/io.ashx?type=5&id=57409958&selfId1=23552990&selfId2=0&maxNumber=12&query=
Journal:
PLOS Genetics - PLOS GENET
, vol. 8, no. 6, 2012
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility
Dewi Astuti
,
Mark R Morris
,
Wendy N Cooper
,
Raymond H J Staals
,
Naomi C Wake
,
Graham A Fews
,
Harmeet Gill
,
Dean Gentle
,
Salwati Shuib
,
Christopher J Ricketts
,
Trevor Cole
,
Anthonie J van Essen
http://academic.research.microsoft.com/io.ashx?type=5&id=56593577&selfId1=23552990&selfId2=0&maxNumber=12&query=
Journal:
Nature Genetics - NAT GENET
, vol. 44, no. 3, pp. 277-284, 2012
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K D Boyd
,
F M Ross
,
L Chiecchio
,
G P Dagrada
,
Z J Konn
,
W J Tapper
,
B A Walker
,
C P Wardell
,
W M Gregory
,
A J Szubert
,
S E Bell
,
J A Child
http://academic.research.microsoft.com/io.ashx?type=5&id=56564065&selfId1=23552990&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 2, pp. 349-355, 2012
Early allo-SCT for AML with a complex aberrant karyotype—results from a prospective pilot study
C Schmid
,
M Schleuning
,
J Tischer
,
E Holler
,
K-H Haude
,
J Braess
,
C Haferlach
,
H Baurmann
,
D Oruzio
,
J Hahn
,
K Spiekermann
,
G Schlimok
http://academic.research.microsoft.com/io.ashx?type=5&id=56543841&selfId1=23552990&selfId2=0&maxNumber=12&query=
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 47, no. 1, pp. 46-53, 2012
Comments